Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 359 medicines
Health Canada · 224 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
SFDA · 163 medicines · Historical list
AEMPS · 160 medicines
CBG-MEB · 97 medicines
AIFA · 91 medicines
HSA · 47 medicines
FDA · 43 medicines
MS · 35 medicines · Historical list
ALIMS · 31 medicines
HALMED · 21 medicines
PHARMAC · 16 medicines
TFDA · 2 medicines · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
43 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Amoxicillin | United States | 250MG, 500MG | capsule | Marketed | Mylan |
| Amoxicillin | United States | 500MG, 875MG | tablet | Marketed | Sun Pharm Inds LTD |
| Amoxicillin | United States | 125MG/5ML, 200MG/5ML, 250MG/5ML … | for suspension | Marketed | Hikma |
| Amoxicillin | United States | 125MG, 200MG, 250MG … | tablet, chewable | Marketed | Teva |
| Amoxicillin | United States | 200MG, 400MG | tablet, for suspension | Not marketed | Aurobindo Pharma LTD |
| Amoxicillin Pediatric | United States | 50MG/ML | for suspension | Marketed | Teva |
| Amoxicillin and Clavulanate PotassiumCombination | United States | 1GM; 62.5MG BASE | tablet, extended release | Marketed | Sandoz |
| Amoxicillin and Clavulanate PotassiumCombination | United States | 125MG/5ML; 31.25MG BASE/5ML, 200MG/5ML; 28.5MG BASE/5ML, 250MG/5ML; 62.5MG BASE/5ML … | for suspension | Marketed | Hikma Pharms |
| Amoxicillin and Clavulanate PotassiumCombination | United States | 250MG; 125MG BASE, 500MG; 125MG BASE, 875MG; 125MG BASE | tablet | Marketed | Deva Holding As |
| Amoxicillin and Clavulanate PotassiumCombination | United States | 200MG; 28.5MG BASE, 400MG; 57MG BASE | tablet, chewable | Marketed | Teva |
| Amoxil | United States | 125MG/5ML, 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | for suspension | Marketed | Glaxosmithkline |
| Amoxil | United States | 250MG, 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 500MG … | capsule | Marketed | Glaxosmithkline |
| Lansoprazole, Amoxicillin and Clarithromycin (Copackaged)Combination | United States | 500MG; 500MG; 30MG | capsule, tablet, capsule, delayed rel pellets | Marketed | Rising |
| Amoxil | United States | 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 200MG, 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet, chewable | Not marketed | US Antibiotics |
| Amoxil | United States | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | US Antibiotics |
| Augmentin XRCombination | United States | 1GM; 62.5MG BASE | tablet, extended release | Marketed | US Antibiotics |
| Augmentin '125'Combination | United States | 125MG/5ML; 31.25MG BASE/5ML | for suspension | Marketed | US Antibiotics |
| Augmentin '250'Combination | United States | 250MG/5ML; 62.5MG BASE/5ML | for suspension | Marketed | US Antibiotics |
| Augmentin '875'Combination | United States | 875MG; 125MG BASE | tablet | Marketed | US Antibiotics |
| Augmentin Es-600Combination | United States | 600MG/5ML; 42.9MG BASE/5ML | for suspension | Marketed | US Antibiotics |
| TaliciaCombination | United States | 250MG; 10MG BASE; 12.5MG | capsule, delayed release | Marketed | Talicia Holdings |
| Voquezna Dual PakCombination | United States | 500MG; 20MG BASE | capsule, tablet | Marketed | Phathom |
| Voquezna Triple PakCombination | United States | 500MG; 500MG; 20MG BASE | capsule, tablet, tablet | Marketed | Phathom |
| Augmentin '200'Combination | United States | 200MG/5ML; 28.5MG BASE/5ML | for suspension | Not marketed | US Antibiotics |
| Augmentin '400'Combination | United States | 400MG/5ML; 57MG BASE/5ML | for suspension | Not marketed | US Antibiotics |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
